Senores Pharmaceuticals has received Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practices (GMP) certification for the manufacturing facility of its subsidiary, Ratnatris Pharmaceuticals, located in Mehsana, Gujarat.
The certification was issued by Ukraine's State Service on Medicines and Drugs Control (SMDC) on November 16, 2026, and received by the company on November 17, 2026. It is expected to support Senores Pharmaceuticals in pursuing regulatory approvals across semi-regulated pharmaceutical markets.
The certification covers both injectable and oral solid dosage manufacturing, enabling the company to expand the market reach of its product portfolio.
Commenting on the development, Swapnil Shah, Managing Director of Senores Pharmaceuticals, said the certification would provide access to additional markets and support the expansion of the company's injectable and oral solid dosage portfolio.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy